Skip to content

Effect of intravenous dexmeditomidine on duration and intensity of brachial plexus block

A randomized placebo control double blinded comparison of effect of intravenous dexmeditomidine on duration and intensity of brachial plexus block

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2018/03/012445
Enrollment
30
Registered
2018-03-09
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: dexmeditomidine: 2ml(100mcg/ml) of dexmeditomidine was diluted in a 50 cc syringe and intravenous infusion was started at 5-7 ml/hr till the end of surgery Control Intervention1: dexmed

Sponsors

SETH G S MEDICAL COLLEGE
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.All patients undergoing surgeries of fore arm, wrist and hand with American Society of Anesthesiology physical status classification designated I, II.

Exclusion criteria

Exclusion criteria: 1.Patient with bleeding tendencies and coagulopathy. 2.Patients with known local anesthetic allergy. 3.Patients with liver and renal diseases. 4.Patients with poor Glasgow coma scale. 5.Pregnant and lactating females. 6.Patients with history of intake of other α2. Adrenergic receptor agonistic drugs.

Design outcomes

Primary

MeasureTime frame
increase in intensity and duration of sensory and motor blockTimepoint: Sensory and motor block were assessed every 10min for the first 120min and thereafter every 20min during surgery and postoperatively.

Secondary

MeasureTime frame
nausea, vomiting, bradycardia, hypotension, hypertensionTimepoint: every 10 minutes intraoperatively

Countries

India

Contacts

Public ContactANURAG JAIN

SETH G S MEDICAL COLLEGE AND KEM HOSPITAL

swetavs@gmail.com09869078541

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026